<DOC>
	<DOCNO>NCT01596595</DOCNO>
	<brief_summary>Post-approval study implant lead provide opportunity observe assess patient outcome technology performance real-world setting . The goal study evaluate , document report appropriate clinical performance , long-term reliability functional integrity Boston Scientific ENDOTAK RELIANCE® 4-SITE™ Lead pulse generator 4-SITE Header .</brief_summary>
	<brief_title>Longitudinal Surveillance Study 4-SITE Lead/Header System</brief_title>
	<detailed_description>The objective LSS 4-SITE Study prospectively determine chronic complication-free rate 4-SITE Lead/Header System order verify clinical performance , long-term reliability functional integrity . The LSS 4-SITE Study non-randomized , multi-center , global clinical investigation subject implant 4-SITE Lead/Header System . The study design collect product performance information , reportable adverse event withdrawal data . The primary purpose study evaluate , document report appropriate clinical performance , long-term reliability functional integrity 4-SITE Lead/Header System . This 4-SITE Lead/Header System consist 4-SITE ENDOTAK® RELIANCE defibrillation lead connect 4-SITE Header ( PG component study ) single dual chamber ( VR DR ) implantable cardioverter defibrillator ( ICD ) cardiac resynchronization therapy ICD ( CRT-D ) BSC pulse generator . Additionally , system-related diagnostic information implant data collect conduct study .</detailed_description>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>medically indicate ICD/CRTD received/plan receive study lead willing longterm followup unwilling comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ICD</keyword>
	<keyword>CRT-D</keyword>
	<keyword>Defibrillation lead</keyword>
</DOC>